Gynecologic Cancer
Feature
Tech-based cancer company raises access concerns
Oncologists say a new company that aims to link patients with cancer care and clinical trials through technology has both positives and negatives...
News
FDA expands approval of 9-valent HPV vaccine
Gardasil-9 is now approved for men and women aged 27-45 years.
Expert Commentary
Addressing your patient's sexual function after cancer
Women undergoing a cancer diagnosis and management plan want their physicians to raise the issue of sexual function, says Dr. Lindau. And...
Article
Agrees that OC use clearly reduces mortality
Opinion
Recommending HPV vaccination: How would you grade yourself?
HPV vaccination is cancer prevention.
From the Journals
Posttherapy HPV DNA a bad omen in cervical cancer
Women with detectable plasma human papillomavirus DNA at the end of chemoradiation were at increased risk for recurrence.
Gynecologic Oncology Consult
Vaginal intraepithelial neoplasia: What to do when dysplasia persists after hysterectomy
From the Journals
Pruritus linked to wide variety of cancers
The odds of specific cancers vary by race.
From the Journals
Cervical cancer screening recommendations vary by age and risk
Guidelines
First-ever gestational trophoblastic neoplasia guidelines published
These rare tumors of pregnancy are generally curable with the appropriate risk-based therapies, experts say.
From the Journals
VEGF inhibitor shows promise in platinum resistant/refractory ovarian cancer
Combining the vascular endothelial growth factor (VEGF) receptor–targeting tyrosine kinase inhibitor apatinib with oral etoposide in people with...